Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT.
Howard R, Zubko O, Gray R, Bradley R, Harper E, Kelly L, Pank L, O’Brien J, Fox C, Tabet N, Livingston G, Bentham P, McShane R, Burns A, Ritchie C, Reeves S, Lovestone S, Ballard C, Noble W, Wilcock G, Nilforooshan R.
Howard R, et al. Among authors: reeves s.
Southampton (UK): NIHR Journals Library; 2020 Apr.
Southampton (UK): NIHR Journals Library; 2020 Apr.
PMID: 32338849
Free Books & Documents.
Review.